Experience of subcutaneous levetiracetam in palliative care

Conclusion: In our experience, subcutaneous levetiracetam was well-tolerated and effective in controlling seizures in palliative care when oral administration or intravenous access was not an option. Randomized controlled trials are needed to elucidate the efficacy and tolerability of subcutaneous levetiracetam in clinical practice.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research